Source document or public record

FDA 510(k) K213061 — SuperCheck Pro Blood Glucose Monitoring System

FDA 510(k) index record K213061. Device: SuperCheck Pro Blood Glucose Monitoring System. Applicant as listed: Ok Biotech Co., Ltd.. Decision date: 2022-10-07.

OtherU.S. Food and Drug Administration (FDA)2022-10-07

Source

"device_name": "SuperCheck Pro Blood Glucose Monitoring System"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K213061.

Device name: SuperCheck Pro Blood Glucose Monitoring System. Applicant as listed: Ok Biotech Co., Ltd..

Decision date: 2022-10-07. Decision wording: Substantially Equivalent.

Product code: NBW. Regulation: 21 CFR 862.1345. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.